2nd Quarter - Report
CAPITOL HILL CONSULTING GROUP for PHRMA
Client
Income
$40,000
Expenses
—
What was lobbied
4 issue areas, each in the filer's own words, with who lobbied on it and where.
Pharmacy PHA
General pharmaceutical issues, including but not limited to: The Federal Food and Drug and Cosmetic Act; the Hatch-Waxman Act; patent reform; drug importation; and drug safety
| Lobbyist | Covered position, as disclosed |
|---|---|
| BILL K BREWSTER | — |
| STEVEN E IRIZARRY | — |
| MONIKA LAWS | — |
Taxation/Internal Revenue Code TAX
General Tax Issues
| Lobbyist | Covered position, as disclosed |
|---|---|
| BILL K BREWSTER | — |
| STEVEN E IRIZARRY | — |
| MONIKA LAWS | — |
Health Issues HCR
General Healthcare Issues
| Lobbyist | Covered position, as disclosed |
|---|---|
| BILL K BREWSTER | — |
| STEVEN E IRIZARRY | — |
| MONIKA LAWS | — |
Medicare/Medicaid MMM
General Medicare and Medicaid issues, including but not limited to, coverage and reimbursement
| Lobbyist | Covered position, as disclosed |
|---|---|
| BILL K BREWSTER | — |
| STEVEN E IRIZARRY | — |
| MONIKA LAWS | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.